thioguanine
treatment
certain
autoimmune
immunologic
related
diseases
therapeutic
effectiveness
6thioguanine
evaluated
past
years
patients
diverse
syndromes
patients
severe
debilitating
disease
unresponsive
conventional
therapy
treated
remissions
occurred
patients
systemic
lupus
erythematosus
patient
dermatomyositis
necrotizing
angiitis
patients
psoriasis
patients
atopic
disease
improvement
occurred
patients
diseases
patients
neurodermatitis
two
patients
scleroderma
experienced
equivocal
benefit
significant
toxicity
attributable
drug
observed
patients
assessment
eventual
value
agents
therapy
requires
study
hypotheses
regarding
mechanism
action
agents
significance
clinical
response
discussed
